Cristine Alves Alves da Costa
Institut de Pharmacologie Moléculaire et Cellulaire
UMR6097 CNRS/UNSA
Equipe labellisée Fondation pour la Recherche Médicale
660 Route des Lucioles
France
Name/email consistency: high
- Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. da Costa, C.A., Sunyach, C., Giaime, E., West, A., Corti, O., Brice, A., Safe, S., Abou-Sleiman, P.M., Wood, N.W., Takahashi, H., Goldberg, M.S., Shen, J., Checler, F. Nat. Cell Biol. (2009)
- DJ-1: a newcomer in Parkinson's disease pathology. da Costa, C.A. Curr. Mol. Med. (2007)
- 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation. Alves da Costa, C., Dunys, J., Brau, F., Wilk, S., Cappai, R., Checler, F. J. Biol. Chem. (2006)
- Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease. Alves da Costa, C., Sunyach, C., Pardossi-Piquard, R., Sévalle, J., Vincent, B., Boyer, N., Kawarai, T., Girardot, N., St George-Hyslop, P., Checler, F. J. Neurosci. (2006)
- Recent insights on the pro-apoptotic phenotype elicited by presenilin 2 and its caspase and presenilinase-derived fragments. da Costa, C.A. Current. Alzheimer. Research (2005)
- Recent advances on alpha-synuclein cell biology: functions and dysfunctions. Alves da Costa, C. Curr. Mol. Med. (2003)
